FDA Inspection 1265665 — Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory
The FDA completed an inspection of Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory on Mar 7, 2025 in Xinchang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 7, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xinchang (China)